Shih-Hong Li

Suggest Changes
Learn More
BACKGROUND In this study, we investigated the efficacy of continuous epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) administration in lung adenocarcinoma patients harboring(More)